These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 6354437

  • 1. Enhancement of doxorubicin and vinblastine sensitivity in anthracycline-resistant P388 cells.
    Ramu A, Shan TC, Glaubiger D.
    Cancer Treat Rep; 1983 Oct; 67(10):895-9. PubMed ID: 6354437
    [Abstract] [Full Text] [Related]

  • 2. Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by perhexiline maleate.
    Ramu A, Fuks Z, Gatt S, Glaubiger D.
    Cancer Res; 1984 Jan; 44(1):144-8. PubMed ID: 6690032
    [Abstract] [Full Text] [Related]

  • 3. Plasma membrane lipid structural order in doxorubicin-sensitive and -resistant P388 cells.
    Ramu A, Glaubiger D, Magrath IT, Joshi A.
    Cancer Res; 1983 Nov; 43(11):5533-7. PubMed ID: 6311408
    [Abstract] [Full Text] [Related]

  • 4. Mechanism of acquired resistance to methotrexate in P388 murine leukemia cells and in their doxorubicin-resistant subline.
    Ramu N, Ramu A, Cole DE, Balis FM, Poplack DG, Pollard HB.
    Isr J Med Sci; 1988 Nov; 24(9-10):477-82. PubMed ID: 2974448
    [Abstract] [Full Text] [Related]

  • 5. Sensitivity to anthracyclines in P388/dx leukaemia cells.
    Bossa R, Dasdia T, Galatulas I, Zunino F.
    Anticancer Res; 1986 Nov; 6(5):1037-9. PubMed ID: 3099628
    [Abstract] [Full Text] [Related]

  • 6. Differences in lipid composition of doxorubicin-sensitive and -resistant P388 cells.
    Ramu A, Glaubiger D, Weintraub H.
    Cancer Treat Rep; 1984 Apr; 68(4):637-41. PubMed ID: 6713419
    [Abstract] [Full Text] [Related]

  • 7. Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists.
    Kessel D, Wilberding C.
    Cancer Res; 1985 Apr; 45(4):1687-91. PubMed ID: 3919944
    [Abstract] [Full Text] [Related]

  • 8. Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by tamoxifen and other triparanol analogues.
    Ramu A, Glaubiger D, Fuks Z.
    Cancer Res; 1984 Oct; 44(10):4392-5. PubMed ID: 6467200
    [Abstract] [Full Text] [Related]

  • 9. Effects of DMDP, a tiapamil analogue, on adriamycin efflux in adriamycin-resistant and -sensitive P388 cells.
    Radel S, Mayhew E, Rustum YM.
    Anticancer Res; 1987 Oct; 7(6):1105-8. PubMed ID: 3442407
    [Abstract] [Full Text] [Related]

  • 10. Acquired vs innate multidrug resistance and the effect of calcium channel blockers.
    Tsuruo T.
    Prog Clin Biol Res; 1986 Oct; 223():203-16. PubMed ID: 3468516
    [Abstract] [Full Text] [Related]

  • 11. Resistance to anthrapyrazoles and anthracyclines in multidrug-resistant P388 murine leukemia cells: reversal by calcium blockers and calmodulin antagonists.
    Klohs WD, Steinkampf RW, Havlick MJ, Jackson RC.
    Cancer Res; 1986 Sep; 46(9):4352-6. PubMed ID: 3460695
    [Abstract] [Full Text] [Related]

  • 12. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors].
    Tsuruo T.
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):750-9. PubMed ID: 6585181
    [Abstract] [Full Text] [Related]

  • 13. Oxygen radical detoxification enzymes in doxorubicin-sensitive and -resistant P388 murine leukemia cells.
    Ramu A, Cohen L, Glaubiger D.
    Cancer Res; 1984 May; 44(5):1976-80. PubMed ID: 6324993
    [Abstract] [Full Text] [Related]

  • 14. Enhancement of sensitivity to adriamycin in resistant P388 leukemia by the calmodulin inhibitor trifluoperazine.
    Ganapathi R, Grabowski D.
    Cancer Res; 1983 Aug; 43(8):3696-9. PubMed ID: 6861140
    [Abstract] [Full Text] [Related]

  • 15. Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.
    Tsuruo T, Iida H, Nojiri M, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1983 Jun; 43(6):2905-10. PubMed ID: 6850602
    [Abstract] [Full Text] [Related]

  • 16. Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells.
    Tsuruo T, Iida H, Kitatani Y, Yokota K, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1984 Oct; 44(10):4303-7. PubMed ID: 6467192
    [Abstract] [Full Text] [Related]

  • 17. Overcoming drug resistance in cancer cells with synthetic isoprenoids.
    Yamaguchi T, Nakagawa M, Shiraishi N, Yoshida T, Kiyosue T, Arita M, Akiyama S, Kuwano M.
    J Natl Cancer Inst; 1986 May; 76(5):947-53. PubMed ID: 3457980
    [Abstract] [Full Text] [Related]

  • 18. Calcium, calmodulin, and protein content of adriamycin-resistant and -sensitive murine leukemic cells.
    Nair S, Samy TS, Krishan A.
    Cancer Res; 1986 Jan; 46(1):229-32. PubMed ID: 3940193
    [Abstract] [Full Text] [Related]

  • 19. A simple fluorometric method to discriminate adriamycin-resistant subline from adriamycin-sensitive parental P388 murine leukemia cell line.
    Dekker K, Kojima N, Yamamoto S, Tatsumi K, Mino M, Yagi K.
    Biochem Int; 1987 Jun; 14(6):997-1001. PubMed ID: 3453100
    [Abstract] [Full Text] [Related]

  • 20. [The effect of finoptin on doxorubicin accumulation in leukemia P-388 cells with induced resistance to the combination of finoptin and doxorubicin].
    Moroz LV, Donenko FV, Borovkova NB, Sitdikova SM, Kabieva AO.
    Biull Eksp Biol Med; 1990 Mar; 109(3):290-2. PubMed ID: 2364157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.